Harborside (HBORF) Stock Price, News & Analysis
Price Move History
- Daily moves over 5%
- 55 139 sessions, December 31, 2021 to July 22, 2022
- Largest daily move
- +17.4% close of June 2, 2022
Company Description
Harborside (OTC: HBORF) is classified in the drug manufacturers—specialty & generic industry within the Healthcare sector and carries a market capitalization of $86.2M.
HBORF has declined 7.5% so far this year. The last closing price was $0.3375.
This page collects what Stock Titan holds for HBORF, including price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.
Stock Performance
Harborside (HBORF) closed at $0.3375 on July 22, 2022. So far this year, the price has lost 7.5%.
HBORF Metrics & Rankings
Price returns through July 22, 2022. Month-to-date and YTD include the first trading day. Ranking links may use different dates.
Latest News
Harborside has 10 recent news articles. Of the recent coverage, 4 articles coincided with positive price movement and 6 with negative movement. Key topics include management, earnings, acquisition. View all HBORF news →
SEC Filings
Financial Highlights
Upcoming Events
Short Interest History
Days to Cover History
HBORF Company Profile & Sector Positioning
Harborside (HBORF) operates in the Drug Manufacturers—Specialty & Generic industry within the broader Healthcare sector.
Investors comparing HBORF often look at related companies in the same sector, including Recro Pharma Inc (REPH), LSFP (LSFP), GNTW (GNTW), Gage Growth (GAEGF), and Mallinckrodt Plc (MNKPF). Comparing financial metrics, valuation ratios, and stock performance across these peers can help investors evaluate HBORF's relative position within its industry.